Your browser doesn't support javascript.
loading
Association of HIV, cardiovascular risk factors, and carotid intimal media thickness: A cross-sectional study in Western Kenya.
Farrant, Maritza T; Masyuko, Sarah J; Kinuthia, John; Osoti, Alfred O; Mogaka, Jerusha N; Temu, Tecla M; Zifodya, Jerry S; Nakanjako, Damalie; Ameda, Faith; Farquhar, Carey; Page, Stephanie T.
Afiliação
  • Farrant MT; Department of Global Health, University of Washington, Seattle, WA, USA.
  • Masyuko SJ; Department of Global Health, University of Washington, Seattle, WA, USA.
  • Kinuthia J; Ministry of Health, Nairobi, Kenya.
  • Osoti AO; Department of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.
  • Mogaka JN; Department of Global Health, University of Washington, Seattle, WA, USA.
  • Temu TM; Department of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya, Tulane University, New Orleans, LA, USA.
  • Zifodya JS; Department of Global Health, University of Washington, Seattle, WA, USA.
  • Nakanjako D; Department of Global Health, University of Washington, Seattle, WA, USA.
  • Ameda F; Department of Medicine, Section of Pulmonary, Critical Care & Environmental Medicine, Tulane University, New Orleans, LA, USA.
  • Farquhar C; Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • Page ST; Department of Radiology, College of Health Sciences, Makerere University, Kampala, Uganda.
Medicine (Baltimore) ; 101(47): e31366, 2022 Nov 25.
Article em En | MEDLINE | ID: mdl-36451447
ABSTRACT
The carotid intimal media thickness (CIMT) is a validated measure of subclinical atherosclerosis. Human immunodeficiency virus (HIV) is a risk factor for cardiovascular disease (CVD) and has been associated with CIMT in North America and Europe; however, there are limited data from Sub-Saharan Africa (SSA). In this cross-sectional study, we measured CIMT in a cohort of 262 people living with HIV (PLHIV) on antiretroviral therapy (ART) for ≥6 months and HIV-negative adults in western Kenya. Using linear regression, we examined the associations between CVD risk factors and CIMT, both overall and stratified according to the HIV status. Among the PLHIV, we examined the association between CIMT and HIV-related factors. Of 262 participants, approximately half were women. The HIV-negative group had a higher prevalence of age ≥55 years (P = .002), previously diagnosed hypertension (P = .02), treatment for hypertension (P = .03), and elevated blood pressure (BP) (P = .01). Overall prevalence of carotid plaques was low (15/262 [6.0%]). HIV-positive status was not significantly associated with a greater mean CIMT (P = .19). In multivariable regression models, PLHIV with elevated blood pressure or treatment for hypertension had a greater mean CIMT (P = .002). However, the CD4 count, viral load, and ART regimen were not associated with differences in CIMT. In the HIV-negative group, older age (P = .006), high total cholesterol levels (P = .01), and diabetes (P = .02) were associated with a greater mean CIMT. In this cross-sectional study of Kenyan adults, traditional CVD risk factors were found to be more prevalent among HIV-negative participants. After multivariable regression analysis, we found no association between HIV status and CIMT, and PLHIV had fewer CVD risk factors associated with CIMT than HIV-negative participants did. HIV-specific factors were not associated with the CIMT.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Soropositividade para HIV / Hipercolesterolemia / Hipertensão Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Soropositividade para HIV / Hipercolesterolemia / Hipertensão Idioma: En Ano de publicação: 2022 Tipo de documento: Article